DSF also showed greater efficacy against SW-620 and Caco-2 CRC cells, compared to the relatively greater resistance to DSF ± OxPt in BRAF (V600E)/ p53 mut HT-29 CRC cells. The gene discussed is TP53; the disease is colorectal carcinoma.